However, the results of previous studies to date tend to indicate a transdiagnostic phenomenon (see Table 1); thus, it is necessary to evaluate GFAP in patients with depression in combination with other alterations, such as altered cytokine levels10. This evidence concerns the gene GFAP and depressive symptom measurement.